Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Kiniksa Pharmaceuticals International (KNSA) Shares Issued: 2021-2025

Historic Shares Issued for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $16.3 million.

  • Kiniksa Pharmaceuticals International's Shares Issued rose 72.88% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.9 million, marking a year-over-year increase of 125.33%. This contributed to the annual value of $17.2 million for FY2024, which is 366.09% up from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Shares Issued stood at $16.3 million, which was up 27.52% from $12.7 million recorded in Q2 2025.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Shares Issued peaked at $16.3 million during Q3 2025, and registered a low of $510,000 during Q1 2023.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Shares Issued value was $2.7 million (recorded in 2024), while the average stood at $4.8 million.
  • Its Shares Issued has fluctuated over the past 5 years, first plummeted by 78.77% in 2022, then soared by 1,022.91% in 2025.
  • Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Shares Issued stood at $1.2 million in 2021, then climbed by 6.44% to $1.3 million in 2022, then decreased by 25.81% to $957,000 in 2023, then spiked by 184.22% to $2.7 million in 2024, then spiked by 72.88% to $16.3 million in 2025.
  • Its Shares Issued stands at $16.3 million for Q3 2025, versus $12.7 million for Q2 2025 and $3.2 million for Q1 2025.